Wegovy tablets are available with PPRX using the following link: https://www.pprx.co.uk/product/wegovy-pill/
Wegovy Tablets Approved in the UK: Everything You Need to Know
In a major development for obesity treatment, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first GLP-1 weight loss tablet for use in the United Kingdom.
The newly approved Wegovy tablet contains semaglutide, the same active ingredient found in Wegovy injections, but in a convenient once-daily oral tablet form.
This approval gives patients an alternative to weekly injections and could significantly increase access to effective weight loss treatment across the UK.
What Are Wegovy Tablets?
Wegovy tablets are an oral form of semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake.
The medication works by mimicking the body's natural GLP-1 hormone, which is released after eating. This helps:
Reduce hunger
Increase feelings of fullness
Decrease food cravings
Support reduced calorie intake
Promote sustainable weight loss
When combined with a reduced-calorie diet and increased physical activity, semaglutide tablets can help patients achieve significant weight loss.
UK Approval of Wegovy Tablets
On 11 June 2026, the MHRA approved semaglutide tablets for weight loss and weight management in adults.
The approval follows extensive clinical trials demonstrating the medicine's safety, quality and effectiveness.
This marks the first time a GLP-1 weight loss medication has been approved in tablet form in the UK.
Who Can Get Wegovy Tablets?
According to the MHRA approval, Wegovy tablets may be prescribed to adults who have:
Obesity
A Body Mass Index (BMI) of 30 kg/m² or above.
Overweight With Weight-Related Conditions
A BMI between 27 and 30 kg/m² and at least one weight-related medical condition, such as:
Type 2 diabetes
High blood pressure
High cholesterol
Sleep apnoea
Cardiovascular risk factors
A healthcare professional must assess suitability before treatment can be prescribed.
Order your Wegovy Tablets here: https://www.pprx.co.uk/product/wegovy-pill/
Wegovy Tablet Dosing Schedule
Treatment begins at a lower dose and gradually increases over time.
The approved dosing schedule is:
Treatment StageDaily DoseStarting Dose1.5mg dailyStep 24mg dailyStep 39mg dailyMaintenance Dose25mg daily
Patients should remain on each dose level for at least one month before increasing.
How to Take Wegovy Tablets Correctly
For the medication to work effectively, patients must follow specific administration instructions.
Wegovy tablets should be:
Taken once daily
Swallowed whole
Taken on an empty stomach
After fasting for at least 8 hours
Take with a small sip of water
After taking the tablet:
No food should be eaten for at least 30 minutes
No drinks should be consumed for at least 30 minutes
Failure to follow these instructions may reduce absorption and effectiveness.
Switching From Wegovy Injections to Tablets
Patients currently using Wegovy 2.4mg injections may be able to transition directly to Wegovy 25mg tablets.
This offers a convenient option for patients who wish to stop weekly injections while continuing semaglutide treatment.
Any transition should be carried out under the supervision of a qualified prescriber.
Wegovy Tablets vs Wegovy Injections
Many patients will wonder whether tablets or injections are the better option.
Benefits of Wegovy Tablets
No injections required
Easier administration for needle-phobic patients
Convenient daily routine
Discreet treatment option
Benefits of Wegovy Injections
Weekly dosing
No fasting requirements before administration
Established treatment pathway
The most appropriate option will depend on individual patient preference and clinical circumstances.
Potential Side Effects of Wegovy Tablets
As with Wegovy injections, the most common side effects involve the digestive system.
These include:
Nausea
Diarrhoea
Constipation
Vomiting
Stomach discomfort
Most side effects are temporary and improve as the body adjusts to treatment.
Are Wegovy Tablets Available on the NHS?
Although approved in the UK, Wegovy tablets are not currently available through NHS prescribing pathways.
Before NHS availability can be considered, the treatment must undergo assessment through the National Institute for Health and Care Excellence (NICE).
Private prescriptions are expected to become available before widespread NHS access.
When Will Wegovy Tablets Be Available in the UK?
The MHRA has approved Wegovy tablets for weight management, but commercial launch dates will depend on manufacturer distribution plans and prescribing pathways.
Patients interested in oral semaglutide for weight loss should monitor developments closely as pharmacies and clinics begin introducing the treatment.
Will PPRX Offer Wegovy Tablets?
PPRX continually reviews new MHRA-approved weight loss treatments to ensure patients have access to the latest evidence-based options.
As soon as Wegovy tablets become commercially available in the UK and appropriate prescribing pathways are established, eligible patients may be able to access treatment through PPRX following a clinical consultation and prescriber approval.
To stay updated on Wegovy tablet availability, visit www.pprx.co.uk
How to buy Wegovy Tablets:
To purchase Wegovy tablets please fill in our online consultation form: https://www.pprx.co.uk/weightlossc/
And then you can purchase the tablets once you are approved: https://www.pprx.co.uk/product/wegovy-pill/
The approval of Wegovy tablets represents a significant milestone in obesity treatment within the UK.
For the first time, patients have the prospect of accessing a clinically proven GLP-1 weight loss medication in tablet form rather than by injection.
For many people, this may remove a major barrier to treatment and help more patients achieve sustainable weight loss through a convenient oral option.
Start Today
Visit https://www.pprx.co.uk
📞 Get in Touch
Visit www.pprx.co.uk or contact us directly to begin your online consultation.
We offer fast, discreet UK-wide delivery and exceptional support throughout your journey.
Mounjaro is a prescription-only medicine. This article is for informational purposes only and does not replace medical advice. Always consult a qualified healthcare provider before starting treatment. nhs
This article is general information, not medical advice, and doesn't replace a consultation. Whether a treatment is right for you — and at what dose — is a decision made with a PPRX clinician who reviews your history.